Cancer vaccine gets orphan drug status


Antigenics Inc. reports the U.S. Food and Drug Administration grantedthe company's personalized cancer vaccine (Oncophage) orphan drug statusfor the treatment of metastatic melanoma. This offers the company potentialmarket exclusivity for seven years from FDA marketing approval.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.